SchneppenheimRBuddeUOyenF. Von Willebrand factor cleaving protease and ADAMTS13 mutations in childhood TTP. Blood. 2003;101:1845-1850.
3.
VeyradierAObertBHaddadE. Severe deficiency of the specific von Willebrand factor-cleaving protease (ADAMTS 13) activity in a subgroup of children with atypical hemolytic uremic syndrome. J Pediatr. 2003;142:310-317.
4.
RobsonWLTsaiHM. Thrombotic thrombocytopenic purpura attributable to von Willebrand factor-cleaving protease inhibitor in an 8-year-old boy. Pediatrics. 2002;109: 322-325.
5.
GeorgeJN. How I treat patients with thrombotic thrombocytopenic purpura: 2010. Blood. 2010;116:4060-4069.
6.
FrankJE. Diagnosis and management of G6PD deficiency. Am Fam Physician. 2005;72:1277-1282.
